Arylsulfatase B (N-Acetylgalactosamine-4-Sulfatase): Potential Role as a Biomarker in Prostate Cancer

Prostate Cancer and Prostatic Diseases - United Kingdom
doi 10.1038/pcan.2013.18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Distinct Effects ofN-Acetylgalactosamine-4-sulfatase and Galactose-6-Sulfatase Expression on Chondroitin Sulfates

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

Recombinant Human N-Acetylgalactosamine-6-Sulfate Sulfatase (GALNS) Produced in the Methylotrophic Yeast Pichia Pastoris

Scientific Reports
Multidisciplinary
2016English

Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?

International Journal of Environmental Research and Public Health
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational HealthPollution
2017English

Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification

Diagnostics
Clinical Biochemistry
2018English

The Role of PTEN as a Cancer Biomarker

Oncoscience
Cancer ResearchOncology
2016English

Mucopolysaccharidosis Type IVA. N-Acetylgalactosamine-6-Sulfate Sulfatase Exonic Point Mutations in Classical Morquio and Mild Cases.

Journal of Clinical Investigation
Medicine
1992English

MALAT1: A Potential Biomarker in Cancer

Cancer Management and Research
Oncology
2018English

In Silico Analysis of Mutations Occurring in the Protein N-Acetylgalactosamine-6-Sulfatase (GALNS) and Causing Mucopolysaccharidosis IVA

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2014English

Cystatin B as a Potential Diagnostic Biomarker in Ovarian Clear Cell Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy